A randomised study on the clinical progress of high-risk elective major gastrointestinal surgery patients treated with olive oil-based parenteral nutrition with or without a fish oil supplement

n-3 Fatty acids have clinical benefits. The primary aim of the present study was the assessment of infection in patients who underwent major high-risk elective gastrointestinal surgery receiving postoperatively fish oil (FO)-supplemented parenteral nutrition (PN), compared with those receiving a sta...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of nutrition Vol. 104; no. 5; pp. 737 - 741
Main Authors Badía-Tahull, María B., Llop-Talaverón, Josep M., Leiva-Badosa, Elisabet, Biondo, Sebastiano, Farran-Teixidó, Leandre, Ramón-Torrell, Josep M., Jódar-Masanes, Ramón
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 14.09.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:n-3 Fatty acids have clinical benefits. The primary aim of the present study was the assessment of infection in patients who underwent major high-risk elective gastrointestinal surgery receiving postoperatively fish oil (FO)-supplemented parenteral nutrition (PN), compared with those receiving a standard olive oil (OO) emulsion. The secondary aims were the assessment of anti-inflammatory response and evaluation of tolerance and safety of these emulsions. A prospective, randomised, double-blind study was performed in patients requiring at least 5 d of PN. An isoenergetic and isoproteic formula was administered: group A received OO alone, while group B received OO that was partially replaced with FO (16·6 %, w/w). End points were outcome measures (mortality, sepsis, infection, hospitalisation days and PN duration), inflammatory response (C-reactive protein (CRP), prealbumin and leucocytes) and safety (TAG and glucose metabolism, and liver and kidney function). Statistical analysis was done using Student's t test and Fisher's exact test (P < 0·05). Twenty-seven patients were evaluated, with thirteen patients receiving FO. In this group, a significantly lower incidence of infections was found (23·1 v. 78·6 %, P = 0·007). CRP, prealbumin and leucocytes were not significantly different between the groups. There were no differences in safety parameters. We conclude that high-risk surgical patients receiving FO-supplemented PN for 5 d present a lower incidence of infection. Emulsions were safe and well tolerated.
Bibliography:http://dx.doi.org/10.1017/S0007114510001066
Conference presentation: This work was presented as a poster in the 30th Congress of ESPEN, Florence, Italy, 13–16 September 2008. It was selected as one of the 100 best communications of the Congress. Clinical trial registration number: 2008-007005-36.Abbreviations: FO, fish oil; OO, olive oil; PN, parenteral nutrition
istex:1E123CBDDDFDA56C1EF7FDEDC77C698C0FC57B39
ark:/67375/6GQ-DW7CNBBH-Z
ArticleID:00106
PII:S0007114510001066
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-News-1
ObjectType-Feature-3
ISSN:0007-1145
1475-2662
DOI:10.1017/S0007114510001066